Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hangzhou Vega is an active China-based health-related ingredients and animal health company operating under the VEGA or Vega Group brand. The company markets a broad portfolio spanning pharmaceutical ingredients, vitamins, amino acids, food ingredients, feed additives, probiotics, disinfectants, medical supplies, and related packaging and equipment. Its business appears to be primarily commercial rather than a drug-development biotech model, with an emphasis on supply, formulation, and export of nutrition, animal health, and API products. Public-facing materials also describe manufacturing sites in Anji and a one-stop additives platform serving feed, food, and healthcare-related markets. The company is best characterized as a commercial life science and animal-health supplier rather than a clinical-stage therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hangzhou Vega.